Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
---|---|---|---|---|---|---|
ARQT
|
Orbimed Advisors LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 200,000 Reduced 10.51% |
$4,142,000
$20.71 p/Share
|
Apr 08
2022 |
NLSN
|
Windacre Partnership LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,601,600 Added 12.38% |
$265,100,182
$27.61 p/Share
|
Apr 08
2022 |
CFLT
|
Brad Gerstner
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 135,000 Added 2.3% |
$5,208,300
$38.58 p/Share
|
Apr 08
2022 |
GMS
|
Coliseum Capital Management, LLC |
BUY
Open market or private purchase
|
Indirect | 60,000 Added 1.0% |
$2,886,000
$48.1 p/Share
|
Apr 08
2022 |
SONN
|
Donald J. Griffith
Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 4,507 Reduced 4.07% |
$1,668
$0.37 p/Share
|
Apr 08
2022 |
RBLX
|
Manuel Bronstein
Chief Product Officer |
SELL
Open market or private sale
|
Direct | 1 Reduced 0.0% |
$43
$43.34 p/Share
|
Apr 07
2022 |
ETNB
|
Michael R Hayden |
BUY
Open market or private purchase
|
Indirect | 10,000 Added 0.0% |
$34,800
$3.48 p/Share
|
Apr 07
2022 |
OEC
|
Robert G. Hrivnak
Chief Accounting Officer |
BUY
Open market or private purchase
|
Indirect | 3 Added 0.0% |
$43
$14.47 p/Share
|
Apr 07
2022 |
AHH
|
Eric E. Apperson
President of Construction |
BUY
Open market or private purchase
|
Direct | 710 Added 0.95% |
$10,167
$14.32 p/Share
|
Apr 07
2022 |
TLYS
|
Fund 1 Investments, LLC |
BUY
Open market or private purchase
|
Indirect | 22,300 Added 0.0% |
$202,261
$9.07 p/Share
|
Apr 07
2022 |
AZO
|
William C Rhodes Iii
Executive Chairman |
SELL
Bona fide gift
|
Indirect | 3,723 Reduced 100.0% |
-
|
Apr 07
2022 |
EMBK
|
Patricia Chiodo
Director |
BUY
Exercise of conversion of derivative security
|
Direct | 367 Added 12.56% |
-
|
Apr 07
2022 |
GHST
|
Esterino Castellazzi
Pres/Principal Acctg Officer |
SELL
Bona fide gift
|
Direct | 7,500,000 Reduced 23.12% |
-
|
Apr 07
2022 |
DCGO
|
Stephen Sugrue
Chief Compliance Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 16,128 Added 50.0% |
$52,416
$3.25 p/Share
|
Apr 07
2022 |
ADBE
|
Ann Lewnes
EVP, CMO, Corp Strategy & Dev |
SELL
Bona fide gift
|
Direct | 1,128 Reduced 4.26% |
-
|
Apr 07
2022 |
MULN
|
Kerri Sadler
CAO |
SELL
Bona fide gift
|
Direct | 2,000 Reduced 0.65% |
-
|
Apr 07
2022 |
BKR
|
William G Beattie
Director |
SELL
Open market or private sale
|
Direct | 5,507 Reduced 30.18% |
$196,545
$35.69 p/Share
|
Apr 07
2022 |
QEGY
|
William Westbrook
CFO |
BUY
Open market or private purchase
|
Direct | 5,000 Added 50.0% |
$1,500
$0.3 p/Share
|
Apr 07
2022 |
LEAT
|
Christopher James Leatt
Director |
SELL
Open market or private sale
|
Indirect | 600 Reduced 0.03% |
$16,056
$26.76 p/Share
|
Apr 07
2022 |
CHE
|
Donald E Saunders
Director |
SELL
Open market or private sale
|
Direct | 405 Reduced 7.06% |
$211,098
$521.23 p/Share
|
Apr 07
2022 |
AMPG
|
Fawad Maqbool
Chairman, CEO |
BUY
Open market or private purchase
|
Direct | 500 Added 0.02% |
$1,365
$2.73 p/Share
|
Apr 07
2022 |
RNGR
|
J. Matt Hooker
Exec VP, Well Services |
BUY
Exercise of conversion of derivative security
|
Direct | 14,013 Added 25.76% |
-
|
Apr 07
2022 |
JKSM
|
Daniel Lee Davis
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 40,000 Reduced 0.16% |
$1,600
$0.04 p/Share
|
Apr 07
2022 |
DKS
|
John Edward Hayes Iii
SVP, General Counsel |
SELL
Bona fide gift
|
Direct | 300 Reduced 0.65% |
-
|
Apr 07
2022 |
SAH
|
Paul P. Rusnak
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 3,793 Added 0.08% |
$155,703
$41.05 p/Share
|
Apr 07
2022 |
HMHC
|
Joseph Patrick Abbott Jr.
EVP, Chief Financial Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 246,187 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
L Gordon Crovitz
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 81,606 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
John F Killian
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 49,141 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Jean S. Desravines
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 73,721 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Lawrence K Fish
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 268,378 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Alejandro Reyes
SVP, Chief People Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 45,052 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Matthew M. Fields
EVP, GM, Suppl Curriculum |
SELL
Sale (or disposition) back to the issuer
|
Direct | 70,782 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
John J Lynch Jr
President and CEO |
SELL
Sale (or disposition) back to the issuer
|
Direct | 579,569 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Tracey Drake Weber
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 94,954 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Michael Dolan
SVP, Controller |
SELL
Sale (or disposition) back to the issuer
|
Direct | 28,041 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Amy Dunkin
EVP, General Manager, Services |
SELL
Sale (or disposition) back to the issuer
|
Direct | 52,743 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Michael Edmund Evans
EVP, Chief Revenue Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct | 75,486 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
William Frederick Bayers
EVP, Sec. & General Counsel |
SELL
Sale (or disposition) back to the issuer
|
Direct | 115,553 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
Jill A Greenthal
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 60,053 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
James P. O Neill
EVP, GM, Core Curriculum |
SELL
Sale (or disposition) back to the issuer
|
Direct | 132,921 Reduced 100.0% |
-
|
Apr 07
2022 |
HMHC
|
John R Mckernan Jr
Director |
SELL
Sale (or disposition) back to the issuer
|
Direct | 30,429 Reduced 100.0% |
-
|
Apr 07
2022 |
RLTY
|
Yigal Dan Jhirad
Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 1,200 Added 50.0% |
$23,820
$19.85 p/Share
|
Apr 07
2022 |
WBD
|
Adria Alpert Romm
Chief People & Culture Officer |
BUY
Grant, award, or other acquisition
|
Direct | 70,709 Added 48.4% |
-
|
Apr 07
2022 |
RWODR
|
Redwoods Capital LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 37,500 Added 1.19% |
$375,000
$10.0 p/Share
|
Apr 07
2022 |
EKSO
|
Jason C Jones
Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct | 50,000 Added 27.53% |
-
|
Apr 07
2022 |
TTOO
|
Michael Terrence Gibbs
General Counsel |
BUY
Open market or private purchase
|
Direct | 10,000 Added 5.66% |
$4,900
$0.49 p/Share
|
Apr 07
2022 |
TTOO
|
John J Sperzel Iii |
BUY
Open market or private purchase
|
Direct | 30,000 Added 11.92% |
$15,000
$0.5 p/Share
|
Apr 07
2022 |
PMD
|
Peter Kamin
Director |
BUY
Open market or private purchase
|
Indirect | 3,000 Added 1.47% |
$20,040
$6.68 p/Share
|
Apr 07
2022 |
CSPI
|
Joseph R Nerges |
BUY
Open market or private purchase
|
Direct | 2,291 Added 0.51% |
$16,747
$7.31 p/Share
|
Apr 07
2022 |
NOVN
|
James L Bierman
Director |
BUY
Open market or private purchase
|
Direct | 1,000 Added 20.0% |
$3,450
$3.45 p/Share
|
Apr 07
2022 |